Sources

7 Total Sources

FDA Clears Takeda's Orzeyful for 120,000 U.S. Narcolepsy Patients as First Orexin-Mimicking Drug

Smithsonian Magazine67d ago

FDA Approves Takeda's Orzeyful, First Drug Targeting Narcolepsy Type 1 Root Cause

FDA Approves Takeda's Orzeyful for Narcolepsy Type 1, Targeting Orexin Pathway

US FDA approves Takeda's sleep disorder pill | Reuters

Yahoo! Voices67d ago

FDA Approves First Drug to Treat a Cause of Narcolepsy

FDA Approves First Drug to Treat a Cause of Narcolepsy - AOL

Medical Daily68d ago

FDA Approves First Narcolepsy Drug That Targets the Brain Signal Loss Behind the Disorder

linkedin68d ago

narcolepsy #sleepmedicine #nt1 | Sleep Medicine Specialists of South Florida